Treatment of Thalassaemia major with phenylbutyrate and hydroxyurea

被引：57

作者：

Olivieri, NF

Rees, DC

Ginder, GD

Thein, SL

Brittenham, GM

Waye, JS

Weatherall, DJ

机构：

[1] MCMASTER UNIV,MED CTR,DNA DIAGNOST LAB,HAMILTON,ON,CANADA

[2] UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455

[3] CASE WESTERN RESERVE UNIV,METROHLTH MED CTR,CLEVELAND,OH

[4] JOHN RADCLIFFE HOSP,INST MOL MED,MRC,MOL HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND

来源：

LANCET | 1997年 / 350卷 / 9076期

关键词：

D O I：

10.1016/S0140-6736(05)63080-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：491 / 492

页数：2

共 5 条

[1]

GRAIG JE, 1993, BRIT J HAEMATOL, V84, P106

[2]

Olivieri NF, 1996, SEMIN HEMATOL, V33, P24

[3] Clinical and hematological response to hydroxyurea in a patient with Hb lepore/beta-thalassemia [J].

Rigano, P ;

Manfre, L ;

LaGalla, R ;

Renda, D ;

Renda, MC ;

Calabrese, A ;

Calzolari, R ;

Maggio, A .

HEMOGLOBIN, 1997, 21 (03) :219-226

[4] POLYMERASE CHAIN-REACTION AMPLIFICATION APPLIED TO THE DETERMINATION OF BETA-LIKE GLOBIN GENE-CLUSTER HAPLOTYPES [J].

SUTTON, M ;

BOUHASSIRA, EE ;

NAGEL, RL .

AMERICAN JOURNAL OF HEMATOLOGY, 1989, 32 (01) :66-69

[5]

Weatherall DJ, 2008, The thalassaemia syndromes

← 1 →